1. Home
  2. CCAP vs BVS Comparison

CCAP vs BVS Comparison

Compare CCAP & BVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Crescent Capital BDC Inc.

CCAP

Crescent Capital BDC Inc.

HOLD

Current Price

$12.75

Market Cap

492.4M

Sector

Finance

ML Signal

HOLD

Logo Bioventus Inc.

BVS

Bioventus Inc.

HOLD

Current Price

$8.66

Market Cap

482.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CCAP
BVS
Founded
2015
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
492.4M
482.9M
IPO Year
N/A
2016

Fundamental Metrics

Financial Performance
Metric
CCAP
BVS
Price
$12.75
$8.66
Analyst Decision
Buy
Strong Buy
Analyst Count
6
4
Target Price
$16.33
$14.25
AVG Volume (30 Days)
172.9K
306.1K
Earning Date
01-01-0001
06-15-2026
Dividend Yield
13.25%
N/A
EPS Growth
N/A
163.46
EPS
N/A
0.33
Revenue
N/A
$568,087,000.00
Revenue This Year
N/A
$7.42
Revenue Next Year
N/A
$6.46
P/E Ratio
$14.18
$26.06
Revenue Growth
N/A
N/A
52 Week Low
$12.56
$5.81
52 Week High
$17.97
$10.13

Technical Indicators

Market Signals
Indicator
CCAP
BVS
Relative Strength Index (RSI) 37.77 52.81
Support Level $12.56 $6.42
Resistance Level $14.70 $9.01
Average True Range (ATR) 0.42 0.39
MACD -0.01 -0.03
Stochastic Oscillator 23.04 34.81

Price Performance

Historical Comparison
CCAP
BVS

About CCAP Crescent Capital BDC Inc.

Crescent Capital BDC Inc is a business development company structured as an externally managed, closed-end, non-diversified management investment company. The company's primary investment objective is to maximize the total return to its stockholders in the form of current income and capital appreciation through debt and related equity investments. It will seek to achieve its investment objectives by investing in secured debt (including senior secured, unitranche, and second lien debt) and unsecured debt (including senior unsecured, mezzanine, and subordinated debt), as well as related equity securities of private U.S. middle-market companies.

About BVS Bioventus Inc.

Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process. It offers a diverse portfolio of products to serve physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine and neurosurgery. Its portfolio of products is grouped into three verticals based on clinical use: Pain Treatments, Surgical Solutions, and Restorative Therapies. Geographical presence is in the United States which derives key revenue, and International markets.

Share on Social Networks: